Atrás
28
Rango del Día
$52.02
$53.23
Rango de 52 Semanas
$46.01
$72.16
Volumen
1,585,370
Promedio 50D / 200D
$60.87
/
$57.62
Cierre Anterior
$52.43
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 112.3 | 0.2 |
| P/B | 4.3 | 3.0 |
| ROE % | 3.7 | 3.6 |
| Net Margin % | 6.0 | 3.8 |
| Rev Growth 5Y % | 7.0 | 9.9 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$69.33
+31.6%
Low: $62.00
High: $79.00
P/E Futuro
26.55
EPS Futuro
$1.98
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.22B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.15
$3.10 – $3.21
|
1.71B | 1 |
| FY2029 |
$3.03
$2.98 – $3.08
|
1.53B | 1 |
| FY2028 |
$2.52
$2.22 – $2.76
|
1.43B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | $0.43 | $0.46 | +6.0% |
| 2025-11-05 | $0.42 | $0.42 | -0.3% |
| 2025-08-06 | $0.50 | $0.53 | +6.1% |
| 2025-05-07 | $0.51 | $0.56 | +10.2% |
| 2025-02-05 | $0.39 | $0.42 | +8.8% |
| 2024-10-30 | $0.38 | $0.42 | +10.5% |
| 2024-08-07 | $0.49 | $0.49 | -1.0% |
| 2024-05-01 | $0.45 | $0.48 | +6.0% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.69%
Growth (3Y)
-37.00%
Growth (5Y)
-24.21%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 13, 2026 | Feb 27, 2026 | $0.08 | 0.53% |
| Nov 17, 2025 | Nov 28, 2025 | $0.08 | 0.55% |
| Aug 18, 2025 | Aug 29, 2025 | $0.08 | 0.60% |
| May 19, 2025 | May 30, 2025 | $0.08 | 0.65% |
| Feb 14, 2025 | Feb 28, 2025 | $0.08 | 0.49% |
| Nov 08, 2024 | Nov 22, 2024 | $0.08 | 0.42% |
| Aug 19, 2024 | Aug 30, 2024 | $0.08 | 0.43% |
| May 10, 2024 | May 24, 2024 | $0.08 | 0.40% |
| Feb 09, 2024 | Feb 26, 2024 | $0.08 | 0.47% |
| Nov 09, 2023 | Nov 24, 2023 | $0.08 | 0.56% |
| Aug 17, 2023 | Sep 01, 2023 | $0.08 | 0.40% |
| May 12, 2023 | May 26, 2023 | $0.08 | 0.39% |
| Feb 10, 2023 | Feb 27, 2023 | $0.08 | 0.42% |
| Nov 10, 2022 | Nov 28, 2022 | $0.32 | 0.38% |
| Aug 12, 2022 | Aug 29, 2022 | $0.32 | 0.34% |
| May 13, 2022 | May 27, 2022 | $0.32 | 0.35% |
| Feb 10, 2022 | Feb 25, 2022 | $0.32 | 0.30% |
| Nov 10, 2021 | Nov 26, 2021 | $0.32 | 0.25% |
| Aug 13, 2021 | Aug 27, 2021 | $0.32 | 0.27% |
| May 14, 2021 | May 28, 2021 | $0.32 | 0.32% |
Puntos Clave
Revenue grew 6.98% annually over 5 years — modest growth
Earnings declined -56.34% over the past year
ROE of 3.68% is below average
Debt/Equity of 0.23 — conservative balance sheet
Generating 256.55M in free cash flow
P/E of 112.31 — premium valuation
Crecimiento
Revenue Growth (5Y)
6.98%
Revenue (1Y)5.23%
Earnings (1Y)-56.34%
FCF Growth (3Y)8.95%
Calidad
Return on Equity
3.68%
ROIC3.25%
Net Margin6.02%
Op. Margin8.38%
Seguridad
Debt / Equity
0.23
Current Ratio3.46
Interest Coverage12.02
Valoración
P/E Ratio
112.31
Forward P/E26.55
P/B Ratio4.30
EV/EBITDA83.37
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.23% | Revenue Growth (3Y) | 3.58% |
| Earnings Growth (1Y) | -56.34% | Earnings Growth (3Y) | -49.27% |
| Revenue Growth (5Y) | 6.98% | Earnings Growth (5Y) | -14.97% |
| Profitability | |||
| Revenue (TTM) | 1.22B | Net Income (TTM) | 73.40M |
| ROE | 3.68% | ROA | 2.87% |
| Gross Margin | 64.80% | Operating Margin | 8.38% |
| Net Margin | 6.02% | Free Cash Flow (TTM) | 256.55M |
| ROIC | 3.25% | FCF Growth (3Y) | 8.95% |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 3.46 |
| Interest Coverage | 12.02 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.69% |
| Dividend Growth (3Y) | -37.00% | Dividend Growth (5Y) | -24.21% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 112.31 | Forward P/E | 26.55 |
| P/B Ratio | 4.30 | P/S Ratio | 6.76 |
| PEG Ratio | -1.97 | Forward PEG | N/A |
| EV/EBITDA | 83.37 | Fwd EV/EBITDA | 23.32 |
| Forward P/S | 6.73 | Fwd Earnings Yield | 3.77% |
| FCF Yield | 3.11% | ||
| Market Cap | 8.24B | Enterprise Value | 8.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.16B | 1.14B | 1.11B | 931.03M |
| Net Income | 73.40M | 168.11M | 285.26M | 272.05M | 140.41M |
| EPS (Diluted) | 0.46 | 1.05 | 1.76 | 1.66 | 0.87 |
| Gross Profit | 790.27M | 769.73M | 769.82M | 756.50M | 632.85M |
| Operating Income | 102.26M | 206.69M | 298.94M | 296.59M | 237.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.56B | 2.70B | 2.64B | 2.29B | 2.26B |
| Total Liabilities | 639.06M | 635.02M | 672.18M | 593.79M | 691.72M |
| Shareholders' Equity | 1.92B | 2.07B | 1.97B | 1.70B | 1.56B |
| Total Debt | 444.06M | 419.54M | 454.97M | 325.97M | 420.55M |
| Cash & Equivalents | 162.19M | 151.79M | 180.57M | 172.57M | 199.09M |
| Current Assets | 608.30M | 617.42M | 621.48M | 605.56M | 510.61M |
| Current Liabilities | 175.85M | 159.38M | 128.51M | 176.02M | 152.28M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#882 of 1049
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026